Claudio A. Mosse, Ph.D.
Affiliations: | 2000 | University of Virginia, Charlottesville, VA |
Area:
Immunology, Molecular BiologyGoogle:
"Claudio Mosse"Parents
Sign in to add mentor| Victor H. Englehard | grad student | 2000 | UVA | |
| (The antigen processing pathway of tyrosinase, a membrane -associated melanoma protein.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wierda WG, Byrd JC, Abramson JS, et al. (2020) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 185-217 |
| Patel DA, Gopalakrishnan R, Engelhardt BG, et al. (2020) Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma. Bone Marrow Transplantation |
| Wierda WG, Byrd JC, Abramson JS, et al. (2019) NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 12-20 |
| Strickland SA, Shaver AC, Byrne M, et al. (2018) Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia. Leukemia Research. 65: 67-73 |
| Mosse CA, Fitzhenry F, LeNoue-Newton M, et al. (2018) Impact of age on utilization and prognostic value of FLT3 and NPM1 testing in acute myeloid leukemia. Journal of Clinical Oncology. 36: e19008-e19008 |
| Wierda WG, Byrd JC, Abramson JS, et al. (2017) Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 1414-1427 |
| Sherrod AM, Hari P, Mosse CA, et al. (2015) Minimal residual disease testing after stem cell transplantation for multiple myeloma. Bone Marrow Transplantation |
| Salazar KL, Mosse C. (2015) Normal Karyotype in a Case of Acute Myeloid Leukemia With Monocytic Differentiation and Hemophagocytosis by Leukemic Blasts Labmedicine. 46: 64-68 |
| Cornell RF, Jones JE, Mosse CA, et al. (2015) In the Era of Bortezomib-Based Chemotherapy the Presence of Minimal Residual Disease Predicts Progression Free Survival after Autologous Hematopoietic Cell Transplant Blood. 126: 5493-5493 |
| Seegmiller AC, Wasserman A, Kim AS, et al. (2014) Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms. Leukemia & Lymphoma. 55: 601-5 |